Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Allogene Therapeutics (ALLO) Tax Provisions: 2018-2024

Historic Tax Provisions for Allogene Therapeutics (ALLO) over the last 3 years, with Dec 2024 value amounting to $443,000.

  • Allogene Therapeutics' Tax Provisions was N/A to -$131,000 in Q4 2019 from the same period last year, while for Dec 2019 it was -$398,000, marking a year-over-year change of. This contributed to the annual value of $443,000 for FY2024, which is N/A change from last year.
  • Per Allogene Therapeutics' latest filing, its Tax Provisions stood at $443,000 for FY2024, which was up 233.84% from -$331,000 recorded in FY2019.
  • In the past 5 years, Allogene Therapeutics' Tax Provisions registered a high of $443,000 during FY2024, and its lowest value of $443,000 during FY2024.
  • In the last 1 years, Allogene Therapeutics' Tax Provisions had a median value of $443,000 in 2024 and averaged $443,000.